GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Inventories, Finished Goods

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Inventories, Finished Goods : ¥0 Mil (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co Inventories, Finished Goods?

Zhejiang Huahai Pharmaceutical Co's quarterly finished goods increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥2,096 Mil) but then declined from Dec. 2023 (¥2,096 Mil) to Mar. 2024 (¥0 Mil).

Zhejiang Huahai Pharmaceutical Co's annual finished goods increased from Dec. 2021 (¥1,420 Mil) to Dec. 2022 (¥1,868 Mil) and increased from Dec. 2022 (¥1,868 Mil) to Dec. 2023 (¥2,096 Mil).

Zhejiang Huahai Pharmaceutical Co Inventories, Finished Goods Historical Data

The historical data trend for Zhejiang Huahai Pharmaceutical Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huahai Pharmaceutical Co Inventories, Finished Goods Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,054.46 1,206.66 1,420.16 1,867.62 2,095.63

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,972.57 - 2,095.63 -

Zhejiang Huahai Pharmaceutical Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Inventories, Finished Goods
Comparable Companies
SHSE:600518 SHSE:600329 SHSE:600380 SZSE:002262 SHSE:600062 SHSE:603707 SZSE:300142 SHSE:600535 SHSE:600129 SZSE:002773 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Economic Development Zone, Xunqiao Town, Linhai, Taizhou, Zhejiang, CHN, 317024
Website
http://www.huahaipharm.com
Zhejiang Huahai Pharmaceutical Co Ltd provides formulations, active pharmaceutical ingredients, and intermediates in China and internationally. The company also offers pril products, including captopril, enalapril, and lisinopril.
Executives
Chen Bao Hua Director
Shang Fei senior management
Du Jun Director
Su Yan Director
Chen Dun Yuan senior management
Li Hong Director
Guo Si Jia senior management
Li Min senior management
Xu Bo senior management
Wang Jie senior management
Chen Qi Mao senior management
Zhang Hong senior management
Zhang Mei senior management
Zhu Yong Hua Directors, senior managers
Wang Yi Hua senior management

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Headlines

No Headlines